Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Business Wire
Guardant tests for cancer screening, recurrence monitoring and treatment selection will be available to patients through Bayshore HealthCare providers PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has entered into an agreement with Bayshore HealthCare, a leading home and community healthcare service provider in Canada, to offer Guardant’s portfolio of precision oncology tests across the continuum of cancer care through the Bayshore network of clinics in Canada.Bayshore HealthCare provides care to over 350,000 Canadians annually (excluding Quebec), and the agreement will significantly expand access to advanced cancer testing tools for its providers and patients. Bayshore’s clinics will offer Guardant360® tests to inform therapy selection in advanced cancer, the Guardant Reveal™ blood test for minimal residual disease (MRD) detection and recurrence monitoring in early-stage cancer, and the Shield™ bloo
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Mizuho from $100.00 to $120.00. They now have an "outperform" rating on the stock.MarketBeat
- Guardant Health price target raised to $120 from $100 at BofA [Yahoo! Finance]Yahoo! Finance
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at JPMorgan Chase & Co. from $90.00 to $120.00. They now have an "overweight" rating on the stock.MarketBeat
- Guardant Health (NASDAQ:GH) was given a new $155.00 price target on by analysts at Leerink Partners.MarketBeat
- Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- 12/17/25 - Form 4
- GH's page on the SEC website